Loading…
InflaRx N.V. is projected to rise to $2.19 by 2027, a +29% move from its current price of $1.70. IFRX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $1.64 | $1.70 | $1.76 | -0.02% |
| Aug 4 | $1.62 | $1.70 | $1.78 | -0.03% |
| Aug 5 | $1.60 | $1.70 | $1.80 | -0.05% |
| Aug 6 | $1.59 | $1.70 | $1.82 | -0.07% |
| Aug 7 | $1.57 | $1.70 | $1.83 | -0.09% |
| Aug 8 | $1.56 | $1.70 | $1.85 | -0.10% |
| Aug 9 | $1.55 | $1.70 | $1.86 | -0.12% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.55 | $1.70 | $1.86 | -0.12% |
| Week 2 | $1.49 | $1.70 | $1.93 | -0.24% |
| Week 3 | $1.45 | $1.69 | $1.98 | -0.36% |
| Week 4 | $1.41 | $1.69 | $2.02 | -0.49% |
| Week 5 | $1.38 | $1.69 | $2.06 | -0.61% |
| Week 6 | $1.35 | $1.69 | $2.10 | -0.73% |
| Week 7 | $1.33 | $1.69 | $2.14 | -0.85% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
InflaRx N.V. is a clinical-stage biopharmaceutical company that discovers and develops inhibitors using C5a technology in Germany and the United States. Its lead product candidate is vilobelimab, a first-in-class monoclonal anti-human complement factor C5a antibody, which is in Phase 3 clinical trial for the treatment for patients suffering from early septic organ dysfunction.
The company was founded in 2007 and is headquartered in Jena, Germany.
InflaRx operates in the healthcare sector and focuses on inflammatory diseases through C5a-targeted therapies, pursuing multiple programs and collaborations to advance its pipeline.
IFRX is a healthcare stock with a current price of $1.73 and a market capitalization of $254.82M, ranking 3543 by market cap.
The near-term forecast for 2026 shows a min of $0.825, an avg of $1.73, and a max of $2.21, with a neutral sentiment and an ROI of 0.
From 2027 onward, the forecast projects sustained upside, with 2027 avg $2.24, 2028 avg $2.68, 2029 avg $3.48, 2030 avg $5.03, 2031 avg $5.56, 2032 avg $5.76, 2033 avg $6.51, 2034 avg $7.03, 2035 avg $9.08, 2040 avg $14.44 and 2050 avg $39.12.
A major floor 51.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.9% away) — a key level to hold.
The nearest ceiling, 37.1% above — a clean break opens room to run.
A major ceiling 61.2% above — clearing it would confirm fresh momentum.
Key IFRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IFRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.69 | Buy | $1.71 | Sell |
| MA 10 | $1.74 | Sell | $1.75 | Sell |
| MA 20 | $1.89 | Sell | $1.83 | Sell |
| MA 50 | $1.99 | Sell | $1.88 | Sell |
| MA 100 | $1.74 | Sell | $1.76 | Sell |
| MA 200 | $1.42 | Buy | $1.57 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.60 | Neutral |
| Stoch RSI (14) | 31.46 | Neutral |
| CCI (20) | -81.03 | Neutral |
| Williams %R (14) | -86.49 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -15.84 | Sell |
| Bollinger %B (20,2) | 0.22 | Neutral |
| Stochastic %K (14) | 13.51 | Buy |
| TRIX (15) | -0.48 | Sell |
| Awesome (5,34) | -0.21 | Sell |
| Ultimate (7,14,28) | 28.58 | Buy |
| Momentum (10) | -0.15 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 1.67 | Buy |
| ADX (14) | 20.32 | Sell |
| ATR (14) | 0.05 | Info |
The 30-day technical picture is bullish in sentiment. RSI14 is 40, with a 50-day moving average (SMA50) of $2.08 and a 200-day moving average (SMA200) of $1.41.
Near-term support sits at $1.60 and resistance at $2.33. The 30-day price range runs from a low of $1.34 to a high of $2.23, indicating potential for movement within this window as traders assess the next moves.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.825 | $1.70 | $2.17 | 0% | Neutral | |
| $1.71 | $2.19 | $2.99 | +29% | Bullish | |
| $2.00 | $2.66 | $3.80 | +56% | Bullish | |
| $2.49 | $3.41 | $5.04 | +101% | Bullish | |
| $3.39 | $4.77 | $7.26 | +180% | Bullish | |
| $3.77 | $5.43 | $8.49 | +220% | Bullish | |
| $3.91 | $5.76 | $9.21 | +239% | Bullish | |
| $4.22 | $6.36 | $10.37 | +274% | Bullish | |
| $4.58 | $7.03 | $11.68 | +314% | Bullish | |
| $5.69 | $8.92 | $15.07 | +425% | Bullish | |
| $8.53 | $14.63 | $26.56 | +760% | Bullish | |
| $19.00 | $38.25 | $77.00 | +21.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.825 | $1.70 | $1.99 | +0.00% |
| September 2026 | $1.35 | $1.61 | $1.98 | -5.46% |
| October 2026 | $1.39 | $1.67 | $2.08 | +4.11% |
| November 2026 | $1.43 | $1.72 | $2.17 | +3.09% |
| December 2026 | $1.40 | $1.71 | $2.17 | -1.09% |
Click any year to see its month-by-month IFRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, IFRX is projected to trade between $0.825 and $2.17, averaging $1.70 — a potential gain of 0% from today's $1.70. Price action looks broadly range-bound.
InflaRx N.V.'s 2027 outlook centres on $2.19, within a $1.71 to $2.99 range. That is up +29% on the projected 2026 average. That marks a +29% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, IFRX could reach as high as $3.80, with a base case around $2.66 and support toward $2.00 — roughly +56% from $1.70. Momentum favours further upside here.
Expect IFRX to range from $2.49 to $5.04 through 2029. The $3.41 average target implies a +101% move from current prices. That is up +28% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The IFRX price prediction for 2030 points to an average of $4.77 (low $3.39, high $7.26) — a potential gain of +180% on today's $1.70. Momentum favours further upside here.
In 2031, IFRX is projected to trade between $3.77 and $8.49, averaging $5.43 — a potential gain of +220% from today's $1.70. That is up +14% on the projected 2030 average. Buyers look set to stay in control over this stretch.
InflaRx N.V.'s 2032 outlook centres on $5.76, within a $3.91 to $9.21 range. That is up +6% on the projected 2031 average. That marks a +239% change versus current levels. Momentum favours further upside here.
By 2033, IFRX could reach as high as $10.37, with a base case around $6.36 and support toward $4.22 — roughly +274% from $1.70. Buyers look set to stay in control over this stretch.
Expect IFRX to range from $4.58 to $11.68 through 2034. The $7.03 average target implies a +314% move from current prices. That is up +11% on the projected 2033 average. Momentum favours further upside here.
The IFRX price prediction for 2035 points to an average of $8.92 (low $5.69, high $15.07) — a potential gain of +425% on today's $1.70. Buyers look set to stay in control over this stretch.
In 2040, IFRX is projected to trade between $8.53 and $26.56, averaging $14.63 — a potential gain of +760% from today's $1.70. That is up +64% on the projected 2035 average. Momentum favours further upside here.
InflaRx N.V.'s 2050 outlook centres on $38.25, within a $19.00 to $77.00 range. That is up +161% on the projected 2040 average. That marks a +21.5x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in IFRX today (≈ 588.235294 IFRX) could be worth
$22,497.31
+$21,497.31 (+2150%) by 2050 · US Dollar
Based on the average projected IFRX price of $38.25 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IFRXwould be worth at today's price.
$1,000 invested in IFRX on Jul 31, 2025 (≈ 1,104.972411 IFRX) would be worth
$1,878.45
+$878.45 (+87.8%) today · 1.88× · US Dollar
Based on a IFRX entry price of $0.905 vs. today's $1.7.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.74 | $977.01 | -2.3% |
| 1 month ago | $2.33 | $729.61 | -27.0% |
| 3 months ago | $2.1 | $809.52 | -19.0% |
| 6 months ago | $0.974 | $1,745.38 | +74.5% |
| 1 year ago | $0.905 | $1,878.45 | +87.8% |
| All time (5.0y) ago | $2.53 | $671.94 | -32.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IFRX forecast.
Our base-case forecast reaches $3.40 around 2029.
Implied market cap at $3.40: $500.8M
The multi-year forecast shows strong upside potential. By 2030, the average price is projected to be $5.03 with an ROI of 190.6; by 2040 the average price is $14.44 with an ROI of 734.5; and by 2050 the average price is $39.12 with an ROI of 2161.5.
Earlier years trend higher as well, with 2027 avg $2.24 (ROI 29.4), 2028 avg $2.68 (ROI 54.8), and 2029 avg $3.48 (ROI 100.9). The forecast also shows a maximum potential of $83.53 in 2050, illustrating a broad range of possible outcomes.
These figures are estimates and not guarantees; actual results depend on numerous factors, including clinical progress, regulatory decisions, and market dynamics.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $5.03 with an ROI of 190.6.
The forecast indicates bullish long-term upside, with an average price rising to $39.12 by 2050 and an ROI of 2161.5, though these are estimates not guarantees.
Yes. The 2035 forecast lists an average price of $9.08 and a max of $16.04, suggesting that a price above $10 is plausible by 2035.
For 2026, the average price is $1.73, with a min of $0.825 and a max of $2.21; the sentiment is NEUTRAL.
Support is at $1.60 and resistance at $2.33, with a 30-day price range of $1.34 to $2.23.
InflaRx N.V. Community Discussion
0Share your InflaRx N.V. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.